Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Сен. 13, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Сен. 13, 2024
Язык: Английский
International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(3), С. 1240 - 1240
Опубликована: Янв. 31, 2025
Binge eating disorder (BED) is characterized by the rapid overconsumption of palatable food in a short amount time, often leading to obesity. The endocannabinoid system (ECS), involved intake, highly expressed reward-related brain regions and both obesity BED. This study investigated differences ECS expression between these conditions using male Wistar rats exposed specific regimen over six weeks: non-access group (NA) with standard diet, continuous access (CA) free-choice high-fat high-sugar (fcHFHS) diet modeling obesity, an intermittent (IA) fcHFHS Food intake was measured, tissues from nucleus accumbens (NAc), dorsal striatum (DS), ventral tegmental area (VTA), rostromedial (RMTg) were analyzed for qPCR mass spectrometry. We identified differential across groups, variations depending on region (striatal or mesencephalic). Correlation analyses revealed dysregulations dependent type (fat sucrose) quantity consumed. Comparative network analysis co-regulation patterns ECS-related genes signatures associated each pattern, highlighting RMTg as key future research behavior.
Язык: Английский
Процитировано
0Frontiers in Behavioral Neuroscience, Год журнала: 2025, Номер 19
Опубликована: Апрель 29, 2025
Food intake is regulated by two systems: homeostatic and hedonic. An imbalance between these systems can induce overconsumption, such as binge eating disorder (BED), associated with dysregulation of the dopamine reward system. The cannabinoid type 2 receptor (CB2R) has been identified in neurons may play an important role motivated behaviors, including food intake. Nevertheless, interaction D4 (DRD4) CB2R binge-like not yet identified. Therefore, present study aims to evaluate effects intraperitoneal administration DRD4 antagonist (L-745870), well coadministration either agonist (HU308) or (AM630), on palatable (PF) adult male mice. We used 34 C57BL6/J All animals were housed individually had ad libitum access standard diet (SD) water. To intake, 1 h PF during 12 baseline test (BET) sessions. Mice then randomly assigned following treatment groups: 1) vehicle; 2) L-745870; 3) L-745870-HU308, 4) L-745870+AM630 be evaluated under effect treatments for three additionally BET Our results show that reduced PF, a induced even more pronounced reduction These findings suggest dopaminergic endocannabinoid modulation mice, where activation participates modulating pathways reducing behavior.
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Май 12, 2025
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Сен. 13, 2024
Язык: Английский
Процитировано
0